MiR-223 enhances lipophagy by suppressing CTSB in microglia following lysolecithin-induced demyelination in mice

Hao Ma,Zhi-lin Ou,Nima Alaeiilkhchi,Yong-quan Cheng,Kai Chen,Jia-yu Chen,Ru-qin Guo,Min-yue He,Shi-yi Tang,Xin Zhang,Zhi-ping Huang,Junhao Liu,Jie Liu,Qing-an Zhu,Zu-cheng Huang,Hui Jiang

DOI: https://doi.org/10.1186/s12944-024-02185-y

2024-06-23

Lipids in Health and Disease

Abstract:Lipid droplet (LD)-laden microglia is a key pathological hallmark of multiple sclerosis. The recent discovery of this novel microglial subtype, lipid-droplet-accumulating microglia (LDAM), is notable for increased inflammatory factor secretion and diminished phagocytic capability. Lipophagy, the autophagy-mediated selective degradation of LDs, plays a critical role in this context. This study investigated the involvement of microRNAs (miRNAs) in lipophagy during demyelinating diseases, assessed their capacity to modulate LDAM subtypes, and elucidated the potential underlying mechanisms involved.

biochemistry & molecular biology,nutrition & dietetics

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore how microRNAs (miRNAs) participate in the autophagic degradation process of lipid droplets (LDs) (i.e., lipophagy) in demyelinating diseases, whether these miRNAs can regulate the subtypes of lipid - droplet - accumulating microglia (LDAM), and to clarify their potential mechanisms of action. Specifically, the research focuses on the role of miR - 223 in lipophagy and its mechanism of promoting lipophagy, reducing lipid burden and inflammatory response by inhibiting cathepsin B (CTSB).

### Research Background
Multiple sclerosis (MS) is a demyelinating disease characterized by inflammation in the central nervous system, resulting in impaired conduction of nerve impulses. In MS, myelin phospholipids and neuronal debris cause neuroinflammation, further exacerbating demyelination. Microglia, as resident phagocytes in the central nervous system, play a crucial role in clearing myelin debris. However, in MS, the clearance ability of microglia is limited, and continuous internalization of myelin debris overloads microglia, leading to a large accumulation of lipid droplets (LDs) in these cells. These lipid - droplet - rich microglia (LDAM) exhibit unique transcriptional characteristics, which are associated with cell dysfunction, and their activities impede remyelination, leading to neurological dysfunction.

### Research Objectives
1. **Explore the role of miRNAs in lipophagy**: Investigate the impact of miRNAs on lipophagy in demyelinating diseases, especially the role of miR - 223.
2. **Evaluate the regulatory ability of miRNAs on LDAM subtypes**: Explore whether miRNAs can regulate the subtypes of lipid - droplet - accumulating microglia (LDAM).
3. **Clarify the potential mechanisms**: Reveal the specific mechanism by which miR - 223 promotes lipophagy, reduces lipid burden and inflammatory response by inhibiting CTSB.

### Main Findings
1. **Accumulation of lipid droplets in the demyelinating state**: Through Oil Red O staining and confocal microscopy, it was found that lipid droplets significantly accumulated in the demyelinating spinal cord.
2. **Enhancement of lipophagy in the demyelinating state**: Through the colocalization study of LC3 and BODIPY, as well as transmission electron microscopy, the increase in the level of lipophagy in microglia after demyelination was confirmed.
3. **The crucial role of miR - 223 in lipophagy**: Through multi - omics analysis, it was found that miR - 223 is a key regulatory gene in lipophagy. In vitro experiments showed that the up - regulation of miR - 223 can inhibit CTSB expression, enhance lipophagy, reduce lipid droplet accumulation, and decrease the expression of the inflammatory mediator IL - 1β.

### Conclusion
These findings indicate that miR - 223 promotes lipophagy by inhibiting CTSB under demyelinating conditions, reducing lipid burden and inflammatory response, and thus may become a potential target for the treatment of demyelinating diseases. This study enhances the understanding of the mechanism of lipophagy and proposes a new method to reduce the inflammatory response in demyelinating diseases by inducing lipophagy.